Lee Dong Hun, Lee Byung Kook, Ryu Seok Jin, Lee Ji Ho, Bae Sung Jin, Choi Yun Hyung
Department of Emergency Medicine, Chonnam National University Hospital, 61469 Gwangju, Republic of Korea.
Department of Emergency Medicine, Chonnam National University Medical School, 61469 Gwangju, Republic of Korea.
Rev Cardiovasc Med. 2024 Sep 23;25(9):340. doi: 10.31083/j.rcm2509340. eCollection 2024 Sep.
The relationship between disseminated intravascular coagulation (DIC) profiles and survival or neurological outcomes in out-of-hospital cardiac arrest (OHCA) patients is well known. In contrast, the relationship between DIC profiles and neurological outcomes in patients with in-hospital cardiac arrest (IHCA) remains unclear. This study sought to examine the correlation between DIC profiles and neurological outcomes in IHCA patients.
A retrospective observational study was conducted on comatose adult IHCA patients treated with targeted temperature management between January 2017 and December 2022. DIC profiles were used to calculate the DIC score, and were measured immediately after the return of spontaneous circulation (ROSC). The primary endpoint was a poor neurological outcome at six months, defined by cerebral performance in categories 3, 4, or 5. Multivariate analysis was used to evaluate the association between DIC profiles and poor neurological outcomes.
The study included 136 patients, of which 107 (78.7%) patients demonstrated poor neurological outcomes. These patients had higher fibrinogen (3.2 g/L vs. 2.3 g/L) and fibrin degradation product levels (50.7 mg/L vs. 30.1 mg/L) and lower anti-thrombin III (ATIII) levels (65.7% vs. 82.3%). The DIC score did not differ between the good and poor outcome groups. In multivariable analysis, fibrinogen (odds ratio [OR], 1.009; 95% confidence intervals [CI], 1.003-1.016) and ATIII levels (OR, 0.965; 95% CI, 0.942-0.989) were independently associated with poor neurological outcomes.
Decreased fibrinogen and ATIII levels after ROSC were an independent risk factor for unfavorable neurological outcomes in IHCA. The DIC score is unlikely to play a significant role in IHCA prognosis in contrast to OHCA.
院外心脏骤停(OHCA)患者中,弥散性血管内凝血(DIC)指标与生存率或神经功能结局之间的关系已为人熟知。相比之下,院内心脏骤停(IHCA)患者中DIC指标与神经功能结局之间的关系仍不明确。本研究旨在探讨IHCA患者中DIC指标与神经功能结局之间的相关性。
对2017年1月至2022年12月期间接受目标温度管理的昏迷成年IHCA患者进行了一项回顾性观察研究。使用DIC指标计算DIC评分,并在自主循环恢复(ROSC)后立即进行测量。主要终点是6个月时神经功能结局不良,定义为脑功能分类为3、4或5级。采用多变量分析评估DIC指标与神经功能结局不良之间的关联。
该研究纳入了136例患者,其中107例(78.7%)患者神经功能结局不良。这些患者的纤维蛋白原水平(3.2 g/L对2.3 g/L)和纤维蛋白降解产物水平(50.7 mg/L对30.1 mg/L)较高,而抗凝血酶III(ATIII)水平较低(65.7%对82.3%)。良好和不良结局组之间的DIC评分没有差异。在多变量分析中,纤维蛋白原(比值比[OR],1.009;95%置信区间[CI],1.003 - 1.016)和ATIII水平(OR,0.965;95% CI,0.942 - 0.989)与神经功能结局不良独立相关。
ROSC后纤维蛋白原和ATIII水平降低是IHCA患者神经功能结局不良的独立危险因素。与OHCA相比,DIC评分在IHCA预后中不太可能发挥重要作用。